TYK-ing all the boxes in psoriasis

  • J Allergy Clin Immunol. 2022 Jun;149(6):1936-1939. doi: 10.1016/j.jaci.2022.03.014.
Christoph Schlapbach  1 ,  Curdin Conrad  2
Affiliations
  • 1. Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • 2. Department of Dermatology, CHUV University Hospital and University of Lausanne, Lausanne, Switzerland. Electronic address: [email protected].
PMID: 35341877 DOI: 10.1016/j.jaci.2022.03.014
Keywords
IFN; IL-17; IL-23; JAK; JAK inhibitor; T(H)17; TYK2; TYK2 inhibitor; deucravacitinib; psoriasis; type I interferon.